SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A. Albornoz, Trent M. Woodruff, Nias Y. G. Peng et al.|Molecular Psychiatry|2022Cited by 178
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|Clinical & Translational Immunology|2021Cited by 62
Molecular clamp stabilised Spike protein for protection against SARS-CoV-2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|Unknown|2020Cited by 15
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike-ACE2 receptor interactionEduardo A. Albornoz, Trent M. Woodruff, Alberto A. Amarilla et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 8
Rapid Application of the Molecular Clamp Platform for SARS-CoV-2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|SSRN Electronic Journal|2020Cited by 1